Ravaioli Alessandra, Crocetti Emanuele, Bucchi Lauro, Guzzinati Stefano, Casella Claudia, Falcini Fabio, Ferretti Stefano, Giuliani Orietta, Mancini Silvia, Puppo Antonella, Toffolutti Federica, Zamagni Federica, Zorzi Manuel, Dal Maso Luigino, Serraino Diego
Registro tumori della Regione Emilia-Romagna, Unità funzionale della Romagna, IRCCS Istituto romagnolo per lo studio dei tumori (IRST) "Dino Amadori", Meldola (FC).
Registro tumori del Veneto, Azienda Zero, Padova.
Epidemiol Prev. 2022 Sep-Dec;46(5-6):356-366. doi: 10.19191/EP22.5-6.A489.095.
to update the Italian estimates of survival for patients with a paediatric cancer, tobacco smoke-associated cancers, and cancers targeted by screening; to assess geographical differences.
population-based descriptive study.
incident cancer cases diagnosed in 2010-2014, with follow-up to 2018, from 17 Italian cancer registries (covering 31% of the national population; 43% of the population residing in the North-Centre of the country and 8% of the population living in the South and Islands).
age-standardized 5-year net survival (NS) by cancer site or type, sex, age, and geographical area.
NS of patients aged ≥15 years with breast, prostate, colorectal, and lung cancers was higher in the North-Centre than in the South and Islands. The overall survival of people diagnosed with cancer in childhood (0-14 years) was 84.3%, with similar values among the geographical macro-areas and between males and females. Women with breast cancer within the current target age of the screening programmes and those in the younger age groups (45-49 years) show similar survival values; the same is true for women with colorectal cancer. In both cases, survival decreased in the age groups after the age of cessation of screening programmes. Survival of patients with tobacco smoke-associated cancers varies according to cancer site (from 11.1% for patients with pancreatic cancer to 79.7% for those with bladder cancer). For most cancer sites, women have higher survival than men.
for adults, a geographical survival gap persists. The results may contribute to the debate on extending the target age for screening programmes and to support initiatives to encourage tobacco smoking cessation even after cancer diagnosis. For patients who receive a cancer diagnosis in childhood, survival similar to highest values internationally.
更新意大利儿童癌症、烟草烟雾相关癌症以及筛查目标癌症患者的生存估计值;评估地理差异。
基于人群的描述性研究。
2010 - 2014年诊断的癌症新发病例,随访至2018年,来自意大利17个癌症登记处(覆盖全国31%的人口;居住在该国中北部的人口占43%,居住在南部和岛屿的人口占8%)。
按癌症部位或类型、性别、年龄和地理区域划分的年龄标准化5年净生存率(NS)。
年龄≥15岁的乳腺癌、前列腺癌、结直肠癌和肺癌患者的净生存率在中北部高于南部和岛屿。儿童期(0 - 14岁)诊断为癌症的患者总体生存率为84.3%,地理大区之间以及男性和女性之间的生存率相似。处于筛查计划当前目标年龄范围内的乳腺癌女性患者以及较年轻年龄组(45 - 49岁)的患者生存率相似;结直肠癌女性患者也是如此。在这两种情况下,筛查计划停止年龄之后的年龄组生存率下降。烟草烟雾相关癌症患者的生存率因癌症部位而异(胰腺癌患者为11.1%,膀胱癌患者为79.7%)。对于大多数癌症部位,女性的生存率高于男性。
对于成年人,地理生存差距仍然存在。这些结果可能有助于关于扩大筛查计划目标年龄的辩论,并支持鼓励即使在癌症诊断后仍戒烟的举措。对于儿童期被诊断为癌症的患者,生存率与国际最高值相似。